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Objective - Risk stratification of patients with non-
sustained ventricular tachycardia (NSVT) and chronic
chagasic cardiomyopathy (CCC).
Methods – Seventy eight patients with CCC and NS-
VT were consecutively and prospectively studied.  All pa-
tients underwent to 24-hour Holter monitoring, radioiso-
topic ventriculography, left ventricular angiography, and
electrophysiologic study. With programmed ventricular
stimulation.
Results - Sustained monomorphic ventricular tachy-
cardia (SMVT) was induced in 25 patients (32%), NSVT in
20 (25.6%) and ventricular fibrillation in 4 (5.1%). In 29
patients (37.2%) no arrhythmia was inducible. During a
55.7-month-follow-up, 22 (28.2%) patients died, 16 due to
sudden death, 2 due to nonsudden cardiac death and 4
due to noncardiac death. Logistic regression analysis sho-
wed that induction was the independent and main varia-
ble that predicted the occurrence of subsequent events
and cardiac death (probability of 2.56 and 2.17, respecti-
vely). The Mantel-Haenszel chi-square test showed that
survival probability was significantly lower in the induci-
ble group than in the noninductible group. The percenta-
ge of patients free of events was significantly higher in the
noninducible group.
Conclusion - Induction of SMVT during programmed
ventricular stimulation was a predictor of arrhythmia oc-
currence cardiac death and general mortality in patients
with CCC and NSVT.
Key words: Chagasic heart disease, nonsustained ventri-
cular tachycardia, electrophysiologic study
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Ventricular arrhythmias have been related to subse-
quent mortality in patients with heart disease encouraging
studies on risk stratification and management of complex
ventricular arrhythmias 1-4. The importance of the progno-
sis is influenced by specific clinical manifestations and their
severity, and the impact of NSVT on valvular heart disease,
congenital heart disease, cardiomyopathy and coronary di-
sease 5. In our environment, CCC has already been reported
because of its prevalence, pathogenesis and prognosis.
Studies were mostly related to conduction disturbances,
syncope investigation, and efficacy of antiarrhythmic dru-
gs in patients with sustained ventricular tachycardia 6-16.
Few studies have been conducted in patients with
CCC and complex ventricular arrhythmias, and hard data
about this subject are lacking. The problems of the studies
that have been conducted are related to population hetero-
geneity, different protocols related to programmed ventricu-
lar stimulation and no correlation analysis between clinical
and laboratory variables 17-21.
The objectives of our study are to analyze clinical va-
riables (sex, age, presence of syncope), laboratory evalua-
tion (conduction disturbances, complex ventricular arrhyth-
mias, segmental abnormalities, ejection fraction) and elec-
trophysiologic studies (induction of sustained monomor-
phic ventricular tachycardia - SMVT) in patients with CCC
and NSVT for risk stratification, and survival study of this
high risk population.
Methods
Seventy-eight patients with CCC and NSVT from the
Clinical Cardiology Division, Hospital São Paulo, Escola
Paulista de Medicina, of the Federal University of São Paulo
were consecutively studied. Inpatients were admitted due to
either syncope or near syncope or due to cardiac failure, or all
of these. Nonsustained ventricular tachycardia was recorded
on electrocardiogram or 24-hour Holter monitoring. Diag-
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nostic criteria for CCC included serologic tests and presence
of heart disease, through history and physical examination,
12-lead electrocardiogram, chest roentgenogram and
echocardiogram. Patients with decompensated congestive
heart failure, coronary heart disease, cardiomyopathy of any
etiology, pregnancy and serious chronic disease were
excluded. We studied 45 male and 33 female patients with
ages ranging from 21 to 68 years (mean 46.4± 10.7).
All patients underwent clinical and laboratory evalua-
tion, including serological reactions (Machado Guerreiro
immunofluorescence), 12-lead electrocardiogram, chest ro-
entgenogram, two-channel 24-hour Holter monitoring,
echocardiogram, radioisotopic ventriculography, left ven-
tricular angiography and electrophysiologic study. All an-
tiarrhythmic drugs were discontinued for at least 5 half-
lives and for 45 days if the drug was amiodarone. Patients
older than 40 years also had coronary angiography perfor-
med by either the Sones or Judkins technique.
Electrophysiologic studies were performed with pa-
tient not sedated, by puncture of femoral right and left veins
to position the electrode catheters, using the percutaneous
modified Seldinger technique. A small amount of local
anesthetic (2% solution of lidocaine hydrochloride) was in-
filtrated into the area. Catheters were inserted and positio-
ned in the high right atrium, in contact with the septum until
a His bundle potential was recorded, in the right ventricular
apex and outflow tract, if it was necessary. During the study,
a bolus of 2500U of heparin was administered followed by
1000U/h. After recording of A-H and H-V intervals, sinus
node function, sinoatrial conduction time, sinus node reco-
very time and analysis of A-V conduction were performed.
Programmed ventricular stimulation was performed in the
right ventricular apex, during two pacing cycle lengths (600
and 450ms), beginning late in diastole and moved progres-
sively earlier until ventricular refractoriness was reached.
The extrastimulus was delivered after a train of 8 paced com-
plexes. If a single extrastimulus (S2) did not induce SMVT, a
second extrastimulus (S3) was added. Double extrastimuli
were introduced starting with an S1-S2 interval 50ms greater
than an effective ventricular refractory period and an S2-S3
interval equal to the S1-S2 interval. The S2-S3 coupling
interval was shortened by 10ms decrements until S3 became
refractory, at which time S2 was decreased by 10ms decre-
ments until S3 evoked a response. This sequence was also
repeated in the right ventricular outflow tract until both ex-
trastimuli reached refractoriness or sustained ventricular ta-
chyarrhythmias were induced. The induction was reprodu-
ced, except in cases of electric cardioversion. Stimulation
was performed with impulses 1-2ms in duration at twice the
diastolic threshold.
All patients with SMVT were treated with amiodarone
or sotalol. Diuretics, digitalis, angiotensin-converting enzy-
me inhibitors and antihypertensive therapy were administe-
red according to indications.
Definitions: A) Ventricular tachycardia - three or more
consecutive ventricular complexes at a rate of more than
100 beats/min; sustained ventricular tachycardia: tachy-
cardia that lasted more than 30 seconds or when cardiovas-
cular collapse was present; nonsustained ventricular tachy-
cardia without cardiovascular collapse that ended sponta-
neously in less than 30 seconds; B) inducible ventricular ta-
chycardia: six or more ventricular complexes induced by pro-
grammed electrical stimulation. If it lasted more than 30 se-
conds or if hemodynamic collapse occurred, it was defined as
sustained; if not, it was defined as nonsustained; C) ventri-
cular fibrillation: sustained ventricular arrhythmia with disor-
ganized electric activity on ECG without distinct QRS
complexes; D) sudden death: unexpected, nontraumatic, in
patients with or without previous disease, occurring within
an hour after the onset of symptoms. The victim should be
well 24-hours before if death was not witnessed 22; E) cardiac
death: that caused by sudden death or due to heart failure; F)
events: included cardiac death, spontaneous sustained
ventricular tachycardia and recurrence of syncope.
Statistical analysis - The Chi-square test with Fisher’s
exact proportion was used to study a possible correlation
between variables; the Mann-Whitney test was used to com-
pare two independent groups; Wilcoxon’s test was used to
compare nondependent groups 23 and the Mantel-Haenszel
test 24 was used for survival analysis between patients with
SMVT, induced and noninduced. A p value of <0.05 was
considered significant and marked with a sign (*). The results
were analyzed using a stepwise logistic regression (program
SAS Institute Inc. SAS/STAT User’s Guide, Version 6).
Results
According to symptoms, 37 patients (47.4%) had syn-
cope, 57 had near syncope and 12 had chest pain. Accor-
ding to the functional classification of congestive heart
failure (New York Heart Association), 38 patients (48.7%)
were in class I, 28 (35.9%) in class II, 8 in class III and 4 in
class IV. Only 2 patients had atrial fibrillation. Sixty-three
patients (80.8%) had conduction disturbances, atrioventri-
cular block, fascicular blocks or bundle branch block.
Twenty-four hour Holter monitoring recorded 11 and 1355
premature ventricular complexes/hour (median 203.5) and
one and 2500 NSVT (median 3.5) episodes. Ejection fraction
varied from 0.10 to 0.80 (mean 0.47, median 0.48). Twenty-
seven patients (34.6%) had segmental abnormalities, which
were located mainly in the apex (59%). None of the patients
had coronary lesions on cineangiography.
Electrophysiologic studies detected sinus node dys-
function defined by prolonged sinus node recovery time in
3 patients (3.8%); HV interval was normal in 60 patients
(76.9%). These evaluations were not made in 8 patients with
pacemakers.
Programmed ventricular stimulation induced SMVT in
25 patients (32%), NSVT in 20 (25.6%), ventricular fibrilla-
tion in 4 (5.1%); in 29 patients noninducible ventricular
arrhythmias (37.2%) occurred. Utilization of 3 extrastimuli
was necessary to induce SMVT in 17 patients (68%). Elec-
trical cardioversion was performed in 13 patients (52%) with
induced ventricular arrhythmias. Cycle length of SMVT va-
ried from 130 to 320 ms (median 240 ms, mean 228 ms).
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Male gender (48%x12%), syncope (47%x22%), age (54 x
45 years) conduction disturbances (40%x7%) and lower ejec-
tion fraction were significantly associated with induction of
SMVT.
Clinical evaluation - Mean clinical follow-up was
55.7±37.7 months (median 50.5), without a significant diffe-
rence between inducible and noninducible groups. During
follow-up 22 deaths (28.2%) occurred, 16 (72.7%) due to
sudden death, 2 (9%) due to nonsudden cardiac death, one
due to stroke, one due to mesenteric thromboembolism, one
due to arrhythmia and one due to sepsis. Spontaneous sus-
tained ventricular tachycardia was noticed in 6 patients
from the inducible group and one from the noninducible
group (p=0.005). Laboratory induction had a positive pre-
dictive value of 24% and a negative predictive value of 98%
for developing clinical SMVT.
Events were observed in 24 patients (sudden death in
16, nonsudden cardiac death in 1, spontaneous SVT in 7,
and syncope recurrence in 3 patients). Episodes of sponta-
neous SVT occurred in patients with sudden death (3
patients) or nonsudden death (one patient). Events occur-
red more often in patients with conduction disturbances
and in the inducible group. Cardiac death occurred more fre-
quently in patients with low ejection fraction and also in the
inducible group. A significant association existed between
sudden or general mortality and SMVT induction (table I).
Therefore, SMVT induction had a positive predictive value
of 63% and a negative predictive value of 80% for occurren-
ce of events. Cardiac mortality had a positive predictive va-
lue of 46% and a negative predictive value of 85%.
Logistic regression analysis had higher probability of
SMVT induction among men and a 2.74 higher induction
probability for every 10 year increase in age. Induction was
also significant, (2.58 times more frequent) for event occur-
rence and cardiac mortality (table II).
During a mean follow-up of 65.0±38.7 months (median
77), 4 patients with induced ventricular fibrillation to pro-
grammed ventricular stimulation did not have events.
Survival curves - Accumulated survival probability
was related to general and cardiac mortality and to the pro-
portion free of events from the whole population studied
(table III).
The Mantel - Haenszel test was used to compare accu-
mulated survival curves considering SMVT induction as a
predictor of survival. Inducible and noninducible patients
had significant differences related to general or cardiac
death and event occurrence (table IV and figures I, II, III).
Discussion
Population characteristics - Chronic chagasic cardio-
myopathy has a male predominance, with a progressive in-
cidence from the third decade of life 25. Seventy-eight chaga-
sic patients with a mean age of 46.4±10.7 years old were
studied. Forty-five patients were males (57.7%).
Table I - Correlation between SMVT and event occurrence,
cardiac death (CD), sudden death (SD) and general
mortality (GM)
Induction of SMVT Events CD SD GM
Present 15 11 10 12
Absent 9 7 6 10
χ2 11.07* 7.74* 7.69* 6.03*
Table II - Regression analysis according to dependent variables:
SMVT induction, presence of events and cardiac mortality (CM),
confidence interval (CI) 95%
                      Variable Odds ratio CI 95%
Dependent Independent
Induction
SMVT Sex 3.3 1.3 – 7.7
Age 1.14 1.06 – 1.23
Events SMVT induction 2.58 1.51 – 4.43
CM SMVT induction 2.17 1.23 – 3.83
Table III – Cumulative survival probability and percentage of
patients free of cardiac events
Cumulated survival
probability
Time General Cardiac Percent free
(months) mortality mortality of events
0 – 12 100 100 100
12 – 24 91.7 93.2 93.1
24 – 36 88.7 90.2 89.9
36 – 48 83.9 87.0 86.7
48 - 60 81.9 85.2 82.9
60 – 72 81.9 85.2 80.7
72 – 84 74.7 78.3 71.2
84 – 96 63.6 70.7 63.2
96 – 108 60.2 70.7 63.2
108 – 120 50.6 63.8 44.4
120 – 132 50.6 63.8 35.6
Table IV – Cumulative survival probability according
general mortality, cardiac mortality and percentage of
patients free of cardiac events in inducible (IND) and
noninducible (NI) patients
Cumulated survival
probability
Time General Cardiac Percent free
(months) mortality mortality of events
IND NI IND NI IND NI
0 – 12 100 100 100 100 100 100
12 – 24 82.9 95.6 87.2 95.6 86.9 95.6
24 – 36 78.4 93.2 82.6 93.2 82.1 93.2
36 – 48 68.6 90.6 72.9 93.2 71.9 93.2
48 – 60 62.9 90.6 67.3 93.2 60.4 93.2
60 – 72 62.9 90.6 67.3 93.2 54.3 93.2
72 – 84 62.9 78.8 67.3 81.5 47.9 81.0
84 – 96 35.9 74.4 42.1 81.5 27.4 81.0
96 – 108 35.9 69.1 42.1 81.5 27.4 81.0
108 – 120 23.9 61.8 31.6 75.0 11.7 64.8
120 – 132 61.8 75.0 50.4
χ2 7.41* 7.41* 15.37*
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Conduction disturbances are present in 60 to 87% of
patients with Chagas disease, and right bundle branch
block with left anterior fascicular block is present in 16 to
39% of patients 26-28. Our study population showed similar
findings with 80.8% of conduction disturbances with pre-
dominance of right bundle branch block associated with
left anterior fascicular block in 32% of patients. Sinus node
dysfunction occurred in 3 patients (3.8%). These data differ
from that in the literature that reported an incidence ranging
from 18 to 45% among patients with decompensated heart
failure. His-Purkinje system dysfunction, corresponding to
an increase in HV interval was found in 10 patients (12.8%),
and this finding was similar to the 13.5% reported by Ben-
chimol 29.
In our study segmental abnormalities occurred in 27
patients (34.6%), 59% in the apex. Reports of this finding in
Chagas disease range between 30 to 93% 30-33.
Finally, like previous studies 34-36, coronary disease
was not detected by coronary angiography in any of the
patients studied.
Correlation between clinical and laboratory variables -
In Brazil 17-21, the induction rate of sustained ventricular
arrhythmias in these patients’ ranges from 0 to 32%. This wide
variation is probably due to population heterogeneity, which
includes patients with isolated premature ventricular beats,
NSVT, ejection fraction ranging from 0.34 to 0.62 and use of
different ventricular stimulation protocols. Studies with
chagasic patients including only patients with NSVT on 24-
hour Holter monitoring were only reported from our ins-
titution 18,20. In the current study the induction rate was 32%.
Contrary to data in the literature 37,38, in our study left ven-
tricular dysfunction was not associated with male gender.
The influence of left ventricular dysfunction on ventri-
cular arrhythmias has been thoroughly studied in coronary
disease 39,40 and in cardiac valve disease 41 but not in dilated
cardiomyopathy 42,43. In our study, ventricular dysfunction
was not related to premature ventricular beats, age or con-
duction disturbances of surface ECG. Santana 44 reported
that complex premature ventricular beats, especially NSVT,
were associated with an increase in cardiothoracic index and
functional class II. Carrasco 37 studied 556 chronic chagasic
patients using left ventricular angiography that showed that
ventricular dysfunction and age were related to the presence
of complex ventricular arrhythmias. Garzon 45 reported that in
901 chagasic patients electrocardiographic abnormalities
were associated with the presence of low ejection fraction.
In our results global left ventricular dysfunction was not
associated with  the presence of segmental abnormalities.
Apical aneurysms were more common in patients with pre-
served left ventricular function than in dilated ventricles
with global dysfunction 46,47.
Sustained monomorphic ventricular tachycardia induc-
tion was predominant in males. The intensity of immunologic
reaction leading to fibrosis may have been higher in males,
intensively compromising the myocardium locally with a
greater number of arrhythmogenic circuits as a consequence.
Logistic regression analysis has also shown greater
probability of SMVT induction with age and an increase of
more than two times for each 10 years of age.
Syncope was also a predictor of SMVT induction.
Electrophysiological studies for syncope investigation in
chagasic individuals found SMVT induction of 47% and
55% 12a,13.
Results in the literature 48 have reported a controver-
sial association between ventricular complexity and SMVT
induction due to programmed ventricular stimulation. Ho-
wever, among chagasic patients, Mendonça 14 reported lack
of association between ventricular arrhythmias or NSVT
with SMVT induction. These results are similar to ours.
Fig. 1 – Total Mortality.
Fig. 2 –Events.
Fig. 3 – Cardiac Mortality.
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Correlation between ventricular dysfunction and
SMVT induction was documented by Da Silva’s study 17
with 26 chagasic patients with frequent premature ventricu-
lar beats; by De Paola 18 with 27 chagasic patients with
NSVT with an induction rate of 19%; and by Mendonça 14
with 60 patients with NSVT, and 20%  inducibility. The pre-
sent study has also found significant correlation between
ventricular dysfunction and SMVT induction.
Evidence suggests that in CCC spontaneous SVT uses
as a reentrant circuit left ventricular areas of fibrosis or aneu-
rysms, mainly in the inferolateral wall followed by the septum
and apex 49,50. Spielman 51 reported induction of ventricular
tachycardia and ventricular fibrillation among patients with
ventricular arrhythmias who had at least one akinetic or
dyskinetic zone revealed by radioisotopic ventriculography.
Buxton 52 has also reported that in patients with coronary
artery disease, ventricular tachycardia was induced more
frequently in the presence of left ventricular aneurysm. In our
study, no significant association existed between SMVT
induction and segmental abnormalities. De Paola 53 found a
significant association between the presence of left ventri-
cular aneurysms and spontaneous SVT in chagasic pati-
ents; but in that study none of the chagasic patients with
NSVT had left ventricular aneurysms.
Variables with significant prognosis - Some variables
have negatively influenced CCC prognosis: male gender,
cardiac failure, complex ventricular arrhythmias, flutter and
atrial fibrillation, ventricular tachycardia, total AV - block
and presence of an inactive electrical zone 14,38,44,54-56
Our results have not shown a higher frequency of
events or cardiac death in male patients. Dias’ study 56 in
Bambuí has not shown gender predominance in CCC deaths
either in 8.3% of total death in 268 cases.
 Atrioventricular block, sinus node dysfunction, neu-
rological mechanism and SVT can be the cause of syncope
among chagasic patients 13. In our study, syncope was not
found to be a predictor of events or cardiac death.
 No correlation existed between age and occurrence of
events or cardiac death in our study. Laranja 57 analyzed 200
deaths caused by Chagas’ disease and found that more
than half (55%) of the patients died when they were 21 to 40
years old. In another study Mady 58 analyzed the survival
predictors in a total of 104 chagasic men and did not find a
relationship between age and death. Our results were similar
to those and can be explained by the fact that NSVT was
found in all patients, and the prognosis was linked to the oc-
currence of sustained ventricular arrhythmias.
We found a significant association between ECG con-
duction disturbance and clinical events, but not between
ECG and death. This fact may be the result of the impact of
drugs for treatment of heart failure like angiotensin-conver-
ting enzyme inhibitors, with a decrease of in mortality 59,60.
The prognostic value of ventricular dysfunction in
CCC is well known 14,44,58. In our patients the mean ejection
fraction was significantly lower in those who died, but this
association was not observed for total cardiac events.
The use of ventricular-programmed simulation for risk
stratification in patients with dilated cardiomyopathy is con-
troversial. In patients with CCC and complex ventricular
arrhythmias, only 2 18,20 of 5 17,21 reports published in the lite-
rature, demonstrate a relationship between inducible ventri-
cular arrhythmias with a prognosis during clinical follow-up.
Mendonça 14 determined that in 60 chagasic patients
with NSVT with mean ejection fraction of 41%, the inducible
rate was 20%. During a mean follow-up time of 49 months,
cardiac events and death were higher among the inducible
patients. Our results have shown a significant association
between event occurrence and SMVT induction, cardiac
death and induction, sudden death (SD) and induction and
finally between induction and death. Also, logistic rejec-
tion showed higher probability of event occurence and
cardiac death among inducible patients, with an odds ratio
of 2.58 and 2.17, respectively. The four patients in whom
ventricular fibrillation was induced had no cardiac events
during a mean follow-up of 65 months. Induction of VF in
these patients was considered a nonspecific response to
programmed ventricular stimulation 61.
Clinical follow-up - Mortality rates in a heterogeneous
population of chagasic patients ranged between 2.8 and
31.1% 54,57,62-66. In our study during a mean follow-up of 55.7
months 22 deaths (28.2 %) occurred. Our high mortality rate
was due to our high risk patients, all with cardiac disease
and NSVT.
During clinical follow-up 7 patients needed a perma-
nent pacemaker; 4 patients had complete AV block and 3 pa-
tients had sinus node dysfunction. Patients with CCC and
AV block have a progressive risk of complete AV block 67.
 Occurrence of spontaneous SMVT during follow-up
was also observed in 6 inducible patients and in one nonin-
ducible patient. Patients with inducible SMVT have a reen-
trant circuit and a higher probability of experiencing clinica-
ly sustained arrhythmias than noninducible patients do 68.
Life expectancy - Despite the social, economic and cli-
nical importance of CCC and its morbidity and mortality,
few studies about the survival of these patients have been
conducted.
Mady 58 studied chagasic patients with heart failure
and found survival expectancy rates of 66% in the first
year, 56% in 3 years, and 48% in 5 years. Santana (44) has
found a survival rate of 48% in patients with NSVT, and
100% in those with normal ECG in 7 years of follow-up. In
our study, the survival rates were 91.7% in the first year;
83.8% in 3 years; 81.9% in 5 years and 50.6% in 10 years and
induction was the most relevant predictor of survival and
occurrence of events in our patients. Differences in survival
rates were probably due to noninclusion in our study of
patients with decompensated congestive heart failure.
Clinical Implications - Patients with CCC and NSVT
with induction of sustained ventricular arrhythmia have a
higher incidence of spontaneous SMVT, cardiac events
and mortality, sudden death and total mortality than the no-
ninducible group. Careful clinical evaluation and prospec-
tive studies may select therapeutic interventions that may
benefit patients who are more prone to cardiac events.
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